pharma imports

Admissions are open for IISER Tirupati one-year Professional Master’s Programmes for 2026-2027 under Biological Data Science (BioDS) and Data Science and Artificial Intelligence (DS-AI). Offered in online mode, programmes target graduates and working professionals from science, technology and allied fields. Curriculum combines theoretical and applied learning with hands-on projects using real datasets. Eligibility includes specified undergraduate or postgraduate qualifications. aim to prepare industry-ready professionals for roles in data science, AI, biotechnology and life sciences sectors.

Country needs time to build up domestic capacities, till then reduce dependence on those ‘perfect’ imports

JPMorgan has shifted its stance on Indian equities to neutral, citing high valuations and geopolitical uncertainties. The brokerage warns of a potential 15% Nifty 50 decline in a worst-case scenario, impacting earnings due to energy supply risks. While the long-term outlook remains robust, near-term caution is advised, with other emerging markets potentially offering better opportunities.

Persistent Systems aims for $2 billion revenue by FY27. CEO Sandeep Kalra sees AI creating new opportunities, not just reducing costs. The company reported steady March quarter revenue. Kalra highlighted a platform-led approach and robust growth in top accounts. Persistent is investing in capabilities for long-term growth and adaptability.

What sets Qdenga apart is that it can be administered regardless of a prior infection. A phased rollout could take place as early as this year

A prolonged Middle East conflict could significantly impact India's exports, both regionally and globally, due to supply chain disruptions, Commerce Secretary Rajesh Agrawal warned. He urged the pharmaceutical industry to reduce reliance on imported raw materials and build stronger domestic capacities to mitigate these risks and ensure continued growth in the sector.

The US has imposed up to 100% tariffs on patented drugs and certain metals, aiming to boost domestic manufacturing. While India's generic drug exports are largely exempt, firms producing branded medicines or inputs for patented drugs may face pressure. Developed nations are expected to bear the brunt of these new measures.

A young doctor resigned on her first day at a private hospital, alleging a system prioritizing profit over patient care. She claimed unnecessary admissions and prolonged ICU stays were encouraged to inflate bills. Her viral video has ignited widespread debate on healthcare ethics and the profit-driven nature of some private hospitals.

Homes Fully Served, Biz Demand 80%

It’s the start of a new financial year, and if you are wondering where to put your money - this article has you covered. We asked five experts what they think is the right portfolio strategy for investors at the current juncture.

US President Trump has imposed steep 100% tariffs on imported patented medicines and new duties on steel, aluminium, and copper. This aims to compel companies to manufacture within the US, with exemptions for some nations. The move seeks to bolster domestic production and national security, building on previous trade actions.

So far, not badly. High forex reserves & low inflation cushioned the first blows. GOI’s managed to avoid a crude oil supply shock. It all depends now, on when the conflict ends